Related references
Note: Only part of the references are listed.Comparative beneficial effects of nebivolol and nebivolol/valsartan combination against mitochondrial dysfunction in angiotensin II-induced pathology in H9c2 cardiomyoblasts
Rukhsana Gul et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2021)
Beta 3 adrenoreceptors protect from hypertrophic remodelling through AMP-activated protein kinase and autophagy
Emilie Dubois-Deruy et al.
ESC HEART FAILURE (2020)
Antihypertrophic Effects of Nebivolol on Neonatal Cardiomyocyte Hypertrophy Models
Isil Ozakca
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2019)
New Insights Into the Role of mTOR Signaling in the Cardiovascular System
Sebastiano Sciarretta et al.
CIRCULATION RESEARCH (2018)
The Future Challenge of Reactive Oxygen Species (ROS) in Hypertension: From Bench to Bed Side
Gabriele Togliatto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Angiotensin II affects inflammation mechanisms via AMPK-related signalling pathways in HL-1 atrial myocytes
Nami Kim et al.
SCIENTIFIC REPORTS (2017)
Nebivolol alleviates aortic remodeling through eNOS upregulation and inhibition of oxidative stress in L-NAME-induced hypertensive rats
Yan Wang et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2017)
Exercise training provides cardioprotection by activating and coupling endothelial nitric oxide synthase via a β3 -adrenergic receptor-AMP-activated protein kinase signaling pathway
Larry A. Barr et al.
MEDICAL GAS RESEARCH (2017)
Regulation of cardiac miR-208a, an inducer of obesity, by rapamycin and nebivolol
Rukhsana Gul et al.
OBESITY (2015)
Chronic beta(1)-adrenergic blockade enhances myocardial beta(3)-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective beta(1)-blocker therapy
Danielle M. Trappanese et al.
BASIC RESEARCH IN CARDIOLOGY (2015)
Nebivolol Protects against Myocardial Infarction Injury via Stimulation of Beta 3-Adrenergic Receptors and Nitric Oxide Signaling
Zheng Zhang et al.
PLOS ONE (2014)
Cooperative interaction between reactive oxygen species and Ca2+ signals contributes to angiotensin II-induced hypertrophy in adult rat cardiomyocytes
Rukhsana Gul et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the transgenic (mRen2) rat
Lixin Ma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Interaction of TNF with Angiotensin II Contributes to Mitochondrial Oxidative Stress and Cardiac Damage in Rats
Nithya Mariappan et al.
PLOS ONE (2012)
Regulation of Overnutrition-Induced Cardiac Inflammatory Mechanisms by Nebivolol
Rukhsana Gul et al.
CARDIORENAL MEDICINE (2012)
RAS-Mediated Adaptive Mechanisms in Cardiovascular Tissues: Confounding Factors of RAS Blockade Therapy and Alternative Approaches
Rukhsana Gul et al.
CARDIORENAL MEDICINE (2012)
Beta3-Adrenoreceptor Stimulation Ameliorates Myocardial Ischemia-Reperfusion Injury Via Endothelial Nitric Oxide Synthase and Neuronal Nitric Oxide Synthase Activation
Juan P. Aragon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Complex Inhibitory Effects of Nitric Oxide on Autophagy
Sovan Sarkar et al.
MOLECULAR CELL (2011)
Nebivolol Improves Diastolic Dysfunction and Myocardial Remodeling Through Reductions in Oxidative Stress in the Zucker Obese Rat
Xinli Zhou et al.
HYPERTENSION (2010)
Beta 3-adrenoreceptor regulation of nitric oxide in the cardiovascular system
An L. Moens et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Inhibition of ADP-ribosyl cyclase attenuates angiotensin II-induced cardiac hypertrophy
Rukhsana Gul et al.
CARDIOVASCULAR RESEARCH (2009)
MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice
Thomas E. Callis et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the β3-adrenoreceptor
An L. Moens et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
A novel signaling pathway of ADP-ribosyl cyclase activation by angiotensin II in adult rat cardiomyocytes
Rukhsana Gul et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Nebivolol induces nitric oxide release in the heart through inducible nitric oxide synthase activation
Angelo Maffei et al.
HYPERTENSION (2007)
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance
Shawna A. Cooper et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Nitric oxide and peroxynitrite in health and disease
Pal Pacher et al.
PHYSIOLOGICAL REVIEWS (2007)
Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats
Matthias Oelze et al.
HYPERTENSION (2006)
Fenofibrate activates AMPK and increases eNOS phosphorylation in HUVEC
H Murakami et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
The involvement of superoxide and iNOS-derived NO in cardiac dysfunction induced by pro-inflammatory cytokines
T Csont et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Modulation of the inflammatory response in cardiovascular disease
DN Granger et al.
HYPERTENSION (2004)
Share Paper
